{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:28:34Z","timestamp":1788413314939,"version":"build-2803163510"},"reference-count":35,"publisher":"Georg Thieme Verlag KG","issue":"04","funder":[{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"crossref","award":["4065"],"award-info":[{"award-number":["4065"]}],"id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prolactin has many physiological effects and seems to be involved in the human\n                    quality of life and well-being. The aim of this study was to describe health\n                    related quality of life, fatigue and daytime sleepiness in women with untreated\n                    hyperprolactinemia. In total 32 women (mean age 37.0\u00b110.9 years) with\n                    verified hyperprolactinemia completed a questionnaire including questions on\n                    fatigue, measured with the Swedish version of the Fatigue Impact Scale (FIS),\n                    propensity to fall in sleep, measured with the Swedish version of the Epworth\n                    Sleepiness Scale (ESS), and Health related quality of life (HRQoL), measured by\n                    the Short-Form-36 scale (SF-36). For comparison Swedish normative data were\n                    used. The women were also interviewed regarding different symptoms related to\n                    hyperprolactinemia and the answers were analyzed using qualitative content\n                    analysis. HRQoL, as measured with SF-36, was significantly lower in all\n                    dimensions, except in physical function, compared to the Swedish reference\n                    population. Total FIS was 54.3 (41.1) and mean score on the ESS was 8.7 (4.2)\n                    indicating increased fatigue and deterioration in night sleep. The women felt\n                    very tired, and several of them rarely felt rested in the morning. The restless\n                    night sleep and the fatigue during the daytime got them to feel feeble and\n                    sometimes to find it difficult to concentrate, which affected both their mood\n                    and life in general. Women diagnosed with hyperprolactinemia reported\n                    deterioration in night sleep, increased rate of fatigue, and a reduced health\n                    related quality of life in comparison with the reference population.<\/jats:p>","DOI":"10.1055\/a-2042-0712","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:03:56Z","timestamp":1677197036000},"page":"266-272","source":"Crossref","is-referenced-by-count":6,"title":["Reduced Health Related Quality of Life, Increased Fatigue, and\n                    Daytime Sleepiness in Women with Hyperprolactinemia"],"prefix":"10.1055","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0624-8325","authenticated-orcid":false,"given":"\u00c5sa","family":"Ernersson","sequence":"additional","affiliation":[{"name":"Department of Health, Medicine and Caring Sciences, Division of Nursing\n                    Science and Reproductive Health, Link\u00f6ping University,\n                    Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Bachrack-Lindstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Health, Medicine and Caring Sciences, Division of Nursing\n                    Science and Reproductive Health, Link\u00f6ping University,\n                    Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Landberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Department of Clinical and\n                    Experimental Medicine, Link\u00f6ping University, Linkoping,\n                    Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-7361","authenticated-orcid":false,"given":"Bertil","family":"Ekman","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Department of Health, Medicine and\n                    Caring Sciences, Link\u00f6ping University, Link\u00f6ping,\n                    Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-6830","authenticated-orcid":false,"given":"Jeanette","family":"Wahlberg","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, \u00d6rebro University, \u00d6rebro,\n                    Sweden"},{"name":"Department of Endocrinology and Department of Health, Medicine and\n                    Caring Sciences, Link\u00f6ping University, Link\u00f6ping,\n                    Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"M E Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","article-title":"Prolactin: the new biology of an old hormone","volume":"64","author":"V Goffin","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"A465","DOI":"10.1016\/j.autrev.2011.11.009","article-title":"Prolactin and autoimmunity","volume":"11","author":"S Shelly","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"S Ezzat","year":"2004","journal-title":"Cancer"},{"key":"ref5","first-page":"292","article-title":"The roles of prolactin, growth hormone, insulin-like growth factor-I, and\n                    thyroid hormones in lymphocyte development and function: insights from genetic\n                    models of hormone and hormone receptor deficiency","volume":"21","author":"K Dorshkind","year":"2000","journal-title":"Endocrine Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/a-1126-4272","article-title":"Immunomodulating effects depend on prolactin levels in patients with\n                    hyperprolactinemia","volume":"52","author":"L Ewerman","year":"2020","journal-title":"Horm Metab Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.comppsych.2016.08.009","article-title":"Hyperprolactinemia, prolactin-related side effects and quality of life in\n                    Chinese psychiatric patients","volume":"71","author":"F R An","year":"2016","journal-title":"Compr Psychiatry"},{"key":"ref8","first-page":"502697","article-title":"The effects of antipsychotics on prolactin levels and women\u2019s\n                    menstruation","author":"S I Bargiota","year":"2013","journal-title":"Schizophr Res Treatment"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/07420528.2014.975353","article-title":"Rotating night shift work, sleep quality, selected lifestyle factors and\n                    prolactin concentration in nurses and midwives","volume":"32","author":"A Bukowska","year":"2015","journal-title":"Chronobiol Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1525-8610(04)70344-8","article-title":"The effects of antipsychotic drug treatment on prolactin concentrations in\n                    elderly patients","volume":"4","author":"B J Kinon","year":"2003","journal-title":"J Am Med Dir Assoc"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.44.89","article-title":"Incidence of hyperprolactinemia in patients with Hashimoto\u2019s\n                    thyroiditis","volume":"44","author":"K Notsu","year":"1997","journal-title":"Endocr J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1026229810876","article-title":"Prolactin, psychological stress and environment in humans: adaptation and\n                    maladaptation","volume":"6","author":"L G Sobrinho","year":"2003","journal-title":"Pituitary"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.schres.2006.11.004","article-title":"Prolactin, menstrual irregularities, quality of life","volume":"91","author":"J Wong","year":"2007","journal-title":"Schizophr Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11102-008-0091-9","article-title":"Quality of life in women with microprolactinoma treated with dopamine\n                    agonists","volume":"11","author":"E Cesar de Oliveira Naliato","year":"2008","journal-title":"Pituitary"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/EJE-07-0259","article-title":"Quality of life is decreased in female patients treated for\n                    microprolactinoma","volume":"157","author":"M Kars","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"ref16","first-page":"675310","article-title":"Long-term health-related quality of life of surgically treated pituitary adenoma\n                    patients: a descriptive study","author":"A Raappana","year":"2012","journal-title":"ISRN Endocrinol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1530\/EJE-14-0941","article-title":"Reduced sleep quality and depression associate with decreased quality of life in\n                    patients with pituitary adenomas","volume":"172","author":"S M Leistner","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-18-0682","article-title":"Psychological effects of dopamine agonist treatment in patients with\n                    hyperprolactinemia and prolactin-secreting adenomas","volume":"180","author":"A G Ioachimescu","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/eje.0.1490201","article-title":"Clinical and biological characterization of macroprolactinemia with and without\n                    prolactin-IgG complexes","volume":"149","author":"J De Schepper","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"ref20","first-page":"167132","article-title":"Macroprolactinemia: diagnostic, clinical, and pathogenic significance","author":"A Shimatsu","year":"2012","journal-title":"Clin Develop Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2004-2234","article-title":"The impact on clinical practice of routine screening for macroprolactin","volume":"90","author":"J Gibney","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2003.01852.x","article-title":"Clinical and radiological features of patients with macroprolactinaemia","volume":"59","author":"M W Strachan","year":"2003","journal-title":"Clin Endocrinol (Oxford)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nedt.2003.10.001","article-title":"Qualitative content analysis in nursing research: concepts, procedures and\n                    measures to achieve trustworthiness","volume":"24","author":"U H Graneheim","year":"2004","journal-title":"Nurse Educ Today"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"C Taft","year":"2001","journal-title":"Qual Life Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). Conceptual framework and item\n                    selection","volume":"30","author":"J E Ware","year":"1992","journal-title":"Med Care"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/11038120510031806","article-title":"Reliability and validity of the Swedish version of the fatigue impact scale\n                    (FIS)","volume":"12","author":"G Flensner","year":"2005","journal-title":"Scand J Occup Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"Measuring the functional impact of fatigue: initial validation of the fatigue\n                    impact scale","volume":"18","author":"J D Fisk","year":"1994","journal-title":"Clin Infect Dis"},{"key":"ref29","first-page":"540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"M W Johns","year":"1991","journal-title":"Sleep Med"},{"key":"ref30","first-page":"376","article-title":"Reliability and factor analysis of the Epworth sleepiness scale","volume":"15","author":"M W Johns","year":"1992","journal-title":"Sleep Medicine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ecl.2014.10.013","article-title":"Health-related quality of life in pituitary diseases","volume":"44","author":"I Crespo","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"M E Molitch","year":"2017","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","article-title":"Quality of life in patients with a pituitary adenoma","volume":"6","author":"M D Johnson","year":"2003","journal-title":"Pituitary"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/1516-4446-2018-0325","article-title":"Body self-image disturbances in women with prolactinoma","volume":"42","author":"H S Pereira","year":"2020","journal-title":"Braz J Psychiatry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11102-014-0561-1","article-title":"Towards a better quality of life (QoL) for patients with pituitary diseases:\n                    results from a focus group study exploring QoL","volume":"18","author":"C D Andela","year":"2015","journal-title":"Pituitary"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1526-4610.2012.02156.x","article-title":"Modification of the SF-36 for a headache population changes patient-reported\n                    health status","volume":"52","author":"J E Magnusson","year":"2012","journal-title":"Headache"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2042-0712.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T22:52:04Z","timestamp":1680735124000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2042-0712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":35,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2023,4,5]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2042-0712","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,23]]},"published":{"date-parts":[[2023,2,23]]}}}